May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Expression of the Putative Stem Cell Marker CD133 in the Human Eye
Author Affiliations & Notes
  • M. Thill
    Ophthalmology,
    University Hospital Hamburg, Hamburg, Germany
  • M. Berna
    Internal Medicine,
    University Hospital Hamburg, Hamburg, Germany
  • K. Schlagner
    Visceral and Hepatobiliary Surgery,
    University Hospital Hamburg, Hamburg, Germany
  • S. Altenähr
    Ophthalmology,
    University Hospital Hamburg, Hamburg, Germany
  • T. Völkel
    Miltenyi Biotec, Bergisch Gladbach, Germany
  • C. Piechaczek
    Miltenyi Biotec, Bergisch Gladbach, Germany
  • U.M. Gehling
    Visceral and Hepatobiliary Surgery,
    University Hospital Hamburg, Hamburg, Germany
  • Footnotes
    Commercial Relationships  M. Thill, None; M. Berna, None; K. Schlagner, None; S. Altenähr, None; T. Völkel, Miltenyi Biotec I; C. Piechaczek, Miltenyi Biotec I; U.M. Gehling, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3090. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Thill, M. Berna, K. Schlagner, S. Altenähr, T. Völkel, C. Piechaczek, U.M. Gehling; Expression of the Putative Stem Cell Marker CD133 in the Human Eye . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3090.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine expression of the putative stem cell marker CD133 in the human eye and to analyse distribution of its n– and c–terminal splice variants. Methods: Paraffin sections were obtained from three healthy human donor eyes discarded from corneal transplantation and from retinoblastoma and pterygium. Immunohistochemistry was performed using monoclonal antibody clone 293C against epitope CD133/1 and the Vectastain Elite ABC kit. Three post–mortem donor eyes were fixed in RNAlater after removal of the cornea. Ocular tissues were carefully dissected and subjected to RNA extraction. Two primer pairs were used to separate c–terminal and n–terminal splice variants and reverse transcriptase PCR was performed. Results: Immunohistochemistry revealed expression of CD133 by the epithelia of the eyelid, the excretory tracts of eyelid glands, the conjunctival and corneal epithelium, the lens epithelium and the epithelium of the iris and ciliary body. The corneal endothelium stained positive for CD133. In the posterior section of the eye, expression of CD133 was demonstrated in the retinal pigment epithelium, the retina and in the optic nerve. In pterygium, single stromal cells stained positive for CD133. PCR analysis confirmed transcription of CD133 in the conjunctiva, iris, lens, ciliary body, RPE and retina. N–terminal splice variant s1 (corresponding to isoform AC133–2) was found in the tissues of the anterior segment of the eye, whereas isoform AC133–1 was revealed in the retina and RPE. A c–terminal splice variant with a deletion of 69 bp was demonstrated in the retina and RPE. Conclusions: We have demonstrated expression of the putative stem cell marker CD133 in most ocular tissues, particularly in epithelia and other cell types with membrane protrusions. Expression of CD133 by stromal cells in pterygium was confirmed. There seems to be a differential distribution of n– and c–terminal splice variants of CD133 in the anterior and posterior section of the human eye.

Keywords: gene/expression • immunohistochemistry • Pterygium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×